REDWOOD CITY, California, June 3 /PRNewswire/ --

Ingenuity Systems, the leading provider of information solutions for life
science researchers, announced the signing of a four year agreement with
Boehringer Ingelheim for Ingenuity Pathway Analysis (IPA). IPA will be used
throughout the Boehringer Ingelheim research and development organization to
unlock novel insights from experimental data and as a general tool for
biological search and exploration.

The agreement provides global access for Boehringer Ingelheim research
scientists to access to the recently released IPA 6, which includes new
biological and chemical content, in addition to Path Designer, an
award-winning set of tools that more clearly communicates information
about networks and pathways.

"We are pleased at this opportunity to become a strategic partner in
Boehringer Ingelheim's research and development efforts," stated Jake
Leschly, CEO, Ingenuity Systems.

About Ingenuity Pathways Analysis

Ingenuity Pathways Analysis is an all-in-one software application that
enables researchers to model, analyze, and understand the complex biological
and chemical systems at the core of life science research. IPA's search
capabilities provide users with access to the highest quality detail-rich
knowledge available on genes, drugs, chemicals, protein families, cellular
and disease processes, and signaling and metabolic pathways. IPA supports
analysis of data from all experimental platforms, and is used at all stages
of the drug discovery and development process, including target
identification and validation, biomarker discovery, molecular toxicology,
metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in
hundreds of peer-reviewed journals.

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions for the
exploration, interpretation, and analysis of life science information. All of
Ingenuity's products and services have one common goal -- to help life
science researchers generate maximum value from all types of biological and
chemical knowledge. Ingenuity offers a broad and flexible range of solutions
that can be tailored to needs of various clients, including academic and
therapeutic area researchers, computational biologists and informatics
departments, and suppliers in the life sciences industry. All of the products
leverage Ingenuity's knowledge base, the largest data base of its kind, which
houses the biological and chemical relationships extracted from scientific
literature. The information is uniquely structured so scientists can ask
complex biological questions to gain rapid insight into their experimental
data or create relevant biological models to move forward in their research.
Today, Ingenuity's solutions are used by thousands of researchers at hundreds
of leading pharmaceutical, biotechnology, and academic research institutions
worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood
City, California with offices in Germany, Switzerland, France, the United
Kingdom, Australia, and Japan. http://www.ingenuity.com.

Web site: http://www.ingenuity.com